share_log
Reuters ·  Jan 8 05:20
Maze Therapeutics - Matrix Capital Management Master Fund LP Beneficially Owned 7.1% of Common Shares Prior to Offering
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment